China reports 2 COVID-19 deaths, first in more than one year
Beijing(AP): China's national health authorities reported two COVID-19 deaths on Saturday, the first recorded rise in the death toll since January 2021, as the country battles an omicron-driven surge.
The deaths, both in northeastern Jilin province, bring the country's coronavirus death toll to 4,638.
China reported 2,157 new COVID-19 cases from community transmission on Saturday, with the majority in Jilin. The province has instituted a travel ban, with people needing permission from police to travel across borders.
China had recorded 4,636 deaths since the pandemic began in the central city of Wuhan in late 2019.
It revised its death toll once in April 2020, adding in new deaths that were not initially counted as the pandemic overwhelmed the city's hospitals and other systems.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Statewide ban on IV Ringer Lactate usage: Dinesh Gundu Rao
Bengaluru: In response to the deaths of postnatal women at Ballari District Hospital, the Karnataka government has temporarily suspended the use of IV Ringer Lactate solution across the state as a precautionary measure, Health Minister Dinesh Gundu Rao announced on Saturday.
Speaking to the media in Bengaluru, the minister explained that doubts about the quality of the IV solution had arisen, prompting the decision. He clarified that Ringer Lactate, along with glucose solutions, has been routinely used in hospitals for years. However, out of the 192 batches supplied by the Karnataka State Drugs Logistics and Warehousing Society, concerns were raised regarding two specific batches.
"In light of these concerns, we stopped the use of all 192 batches as a precaution. Following this, the supplying company obtained a High Court order for testing, and the Central Drugs Laboratory (CDL) conducted an analysis. The CDL report confirmed the usability of the solution, allowing the state to form a technical committee to review and permit the use of certain batches that met quality standards. Despite this, doubts have surfaced specifically at Ballari District Hospital," the minister stated.
To address these concerns, the batches supplied to Ballari Hospital have been sent for anaerobic testing to determine whether the IV solution contributed to the deaths. The test results are expected within a week, after which a final decision on the use of IV Ringer Lactate will be made.
"Until then, we have issued directives to hospitals statewide to suspend the use of IV Ringer Lactate. Every life is important to us, and precautionary measures are essential when suspicions arise," Gundu Rao emphasised.
